Cell line · CVCL_1989
COLO 320
Cancer cell line, Homo sapiens. Colon adenocarcinoma. 35 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. COLO 320. Cell lines, record CVCL_1989. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1989
On this page
Cell line
As Cellosaurus gives it.
- Name
- COLO 320
- Accession
- CVCL_1989
- RRID
- RRID:CVCL_1989
- Synonyms
- COLO-320, Colo-320, Colo 320, COLO #320, COLO320, Colo320, CoLo320, Co320, COLO 320F, Colorado 320
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 55Y
- Category
- Cancer cell line
- Diseases
- Colon adenocarcinoma (NCIt C4349)
- Derived from
- Colon, sigmoid (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-03-31
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers35
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| BET Inhibition Synergizes with RLR Signaling to Enhance Tumor Immunogenicity and T-cell Recognition. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Neural cues differentially modulate colorectal cancer cell behavior depending on patients' genomic background. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Increased vulnerability of colorectal cancer models with high alkylation damage to NTHL1 inactivation. | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| BMP antagonist CHRDL2 enhances the cancer stem-cell phenotype and increases chemotherapy resistance in colorectal cancer. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| USP10 Regulates ZEB1 Ubiquitination and Protein Stability to Inhibit ZEB1-Mediated Colorectal Cancer Metastasis. | Mol Cancer Res | 2023 | Its Methods give the RRID and name the line | PubMed | |
| NIR-II fluorescence imaging-guided colorectal cancer surgery targeting CEACAM5 by a nanobody. | EBioMedicine | 2023 | Its Methods give the RRID and name the line | PubMed | |
| SALL4-related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features. | Mol Oncol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells. | Sci Signal | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Oncogenic mutation in RAS-RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer. | Cancer Sci | 2020 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 35
See all 35 papersRelatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | COLO 320DM | CVCL_0219 | Cell lines | |
| From the same person | COLO 321 | CVCL_K030 | Cell lines |
Cell banks3
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1989
GET https://conductscience.org/api/cell-lines/v1/CVCL_1989/papers?page=2